Has Kayla Schwind received payments from drug or device companies?

Yes. Drug and device makers reported $9,751 in general payments to Kayla Schwind across 407 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kayla Schwind did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kayla Schwind come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kayla Schwind

Family · Davenport, FLNPI 1417686353

Payments from drug & device makers

$9,751in general payments, 2019–2025

Across 407 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$1K
AstraZeneca$910
Incyte Corporation$623
Astellas Pharma US Inc$557
Pfizer$547
Merck$510
plus $5K from 49 others

What the payments were for

Food & beverage$7,99782%
Education$1,25613%
Other$4995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	51	$1,405
AstraZeneca(2 entities)	43	$910
Incyte Corporation	24	$623
Astellas Pharma US Inc	11	$557
Pfizer	23	$547
Merck	25	$510
Johnson & Johnson	21	$499
Daiichi Sankyo Inc.	19	$494
Seagen Inc.	8	$382
Bristol Myers Squibb	15	$362
Sobi, Inc	16	$353
Bayer	18	$321
Eisai Inc.	10	$235
Pharmacosmos Therapeutics Inc.	11	$224
Myriad Genetic Laboratories, Inc.	8	$206
Takeda Pharmaceuticals U.S.A., Inc.	7	$156
Tersera Therapeutics LLC	6	$136
Lilly USA, LLC	6	$127
E.r. Squibb & Sons, L.L.C.	7	$118
Morphosys, US Inc.	3	$117
Sanofi	5	$98
Jazz Pharmaceuticals Inc.	5	$90
Alnylam Pharmaceuticals Inc.	4	$87
Regeneron Healthcare Solutions, Inc.	3	$74
Array Biopharma Inc	4	$74
AVEO Pharmaceuticals, Inc.	3	$69
Genentech USA, Inc.	4	$69
Karyopharm Therapeutics Inc.	3	$63
Gilead	4	$63
AbbVie	3	$62
Foundation Medicine, Inc.	3	$59
Pharmaessentia USA Corporation	2	$48
Pharmacyclics LLC, An Abbvie Company	2	$48
GSK	2	$47
Mirati Therapeutics, Inc.	3	$46
Deciphera Pharmaceuticals Inc.	2	$45
Recordati_rare_diseases_inc.	2	$43
Puma Biotechnology, Inc.	2	$36
Agios Pharmaceuticals, Inc.	2	$34
Sun Pharmaceutical Industries Inc.	1	$32
Taiho Oncology, Inc.	2	$31
Servier Pharmaceuticals LLC	1	$25
Epizyme, Inc.	1	$23
Sumitomo Pharma America, Inc.	1	$20
Stemline Therapeutics Inc.	1	$20
EMD Serono, Inc.	1	$20
G1 Therapeutics, Inc.	1	$19
Genmab U.S., Inc.	1	$18
Kyowa Kirin, Inc.	1	$17
CSL Behring	1	$16
Novocure Inc.	1	$16
Ipsen Biopharmaceuticals, Inc	1	$16
Macrogenics, Inc.	1	$15
Cumberland Pharmaceuticals, Inc.	1	$15
Amgen	1	$12

How this compares

$9,751 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Anastrozole	116	$2,045
SpsSodium Polystyrene Sulfon/Sorb	67	$1,651
Tamoxifen Citrate	31	$1,195
Hydroxyurea	19	$812
Venlafaxine Hcl ErVenlafaxine Hcl	34	$579
Letrozole	14	$514
Gabapentin	15	$342
Ondansetron OdtOndansetron	19	$315
Prochlorperazine Maleate	17	$228
Potassium Chloride	58	$207
Pantoprazole Sodium	12	$116

Paid to pharmacies, not to this prescriber.

Other family in Davenport

John HuffakerVenice$8M
Stephanie MompointMiami$4.5M
Miguel TrujilloMiami Gardens$4.4M
Itsel Cardenas RamonMiami$1M
Lewis HarringtonTampa$954K
Adam StrosbergFort Lauderdale$859K
Danielle PharesFt Lauderdale$713K
David RodriguezHialeah$658K
Donna OrtizOrlando$417K
Patrick SzarazMiami$327K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →